Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Are hybrid umbilical cord blood banks really the best of both worlds?
- Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do “saviour siblings” have in paediatric transplantation?
- NHS maternity units should not encourage commercial banking of umbilical cord blood
- Status of umbilical cord blood transplantation in the year 2001
- Ethical and legal aspects of stem cell practices in Turkey: where are we?
- Public-private partnership in cord blood banking
- Stem cell stories: from bedside to bench
- World's first public-private cord blood bank launched in UK
- Wait a minute? An observational cohort study comparing iron stores in healthy Swedish infants at 4 months of age after 10-, 60- and 180-second umbilical cord clamping
- World's first public-private cord blood bank launched in United Kingdom